Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70153 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Anju Sheokand und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, India. Hauptthemen laut MEDLINE: Glycosides, Neoplasms, Antineoplastic Agents, Phytogenic, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Echinacoside, a naturally occurring phenylethanoid glycoside, primarily derived from medicinal plants such as Cistanche tubulosa and Echinacea angustifolia , has long been valued in traditional medicine for its diverse pharmacological activities, including antidiabetic, anti‐inflammatory, antifatigue, anti‐allergic, antiaging, wound healing, and aphrodisiac effects. Recent research has steadily highlighted echinacoside's promising role as a multi‐targeted oncotherapeutic agent due to its potent anticancer properties. Its antineoplastic efficacy is mediated through multiple mechanisms, including induction of apoptosis, inhibition of metastasis and angiogenesis, and modulation of key oncogenic signaling pathways such as PI3K/Akt/mTOR and MAPK/ERK. Additionally, echinacoside has significant synergistic potential with traditional chemotherapeutics, enhancing cytotoxicity while mitigating systemic toxicity and overcoming drug resistance. Despite compelling evidence for its multi‐targeted anticancer mechanisms, its clinical translation is restricted by various pharmacokinetic challenges, including limited absorption and fast metabolic clearance. Although few reviews have addressed the general pharmacological activities of echinacoside, this article provides a novel and forward‐looking perspective by critically bridging the gap between its multi‐targeted anticancer mechanisms and its translational potential. This manuscript also comprehensively integrates the latest preclinical findings, particularly highlighting emerging nanotechnological and synergistic strategies designed to overcome its bioavailability and stability barrier, thereby uniquely outlining a strategic roadmap for future research to facilitate the clinical application of echinacoside into precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, Kurukshetra University, Kurukshetra, Haryana, India.
- Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.
- Centre of Excellence in Computational Research and Drug Discovery, Department of Bio-Sciences and Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to Be University), Mullana, Amba…
ORCID-Profile: Karan Wadhwa, Gulshan Sharma, Hardeep Singh Tuli
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Sheokand, A., Koli, D., Wadhwa, K., Sharma, G., Pahwa, R., & Tuli, H. S. (2025). Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70153
Vancouver
Sheokand A, Koli D, Wadhwa K, Sharma G, Pahwa R, Tuli HS. Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70153
BibTeX
@article{Sheokand2025,
author = {Sheokand, Anju and Koli, Dolly and Wadhwa, Karan and Sharma, Gulshan and Pahwa, Rakesh and Tuli, Hardeep Singh},
title = {Mechanistic Insights into the Anticancer Potential of Echinacoside: Therapeutic Applications and Future Directions},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70153}
}
EUVIMED